phosphorus has been researched along with decitabine in 3 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (decitabine) | Trials (decitabine) | Recent Studies (post-2010) (decitabine) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 3,804 | 205 | 2,177 |
Protein | Taxonomy | phosphorus (IC50) | decitabine (IC50) |
---|---|---|---|
DNA (cytosine-5)-methyltransferase 1 | Homo sapiens (human) | 0.03 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Azechi, T; Sato, F; Sudo, R; Wachi, H | 1 |
Diao, S; DiNardo, C; DiPippo, AJ; Konopleva, M; Maiti, A; Nichols, ED; Ning, J; Qiao, W | 1 |
Dharmalingam, P; Tan, B; Venkatakrishnan, K | 1 |
3 other study(ies) available for phosphorus and decitabine
Article | Year |
---|---|
5-aza-2'-Deoxycytidine, a DNA methyltransferase inhibitor, facilitates the inorganic phosphorus-induced mineralization of vascular smooth muscle cells.
Topics: Alkaline Phosphatase; Aorta; Azacitidine; Blotting, Western; Cell Differentiation; Cells, Cultured; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Humans; Muscle, Smooth, Vascular; Phosphorus; Real-Time Polymerase Chain Reaction; RNA; Vascular Calcification | 2014 |
Incidence of tumor lysis syndrome in patients with acute myeloid leukemia undergoing low-intensity induction with venetoclax.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Cytarabine; Decitabine; Female; Fluid Therapy; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukocytosis; Male; Middle Aged; Phosphate-Binding Proteins; Phosphorus; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Sulfonamides; Tumor Lysis Syndrome; Urate Oxidase; Uric Acid | 2021 |
Nanoplatform to Investigate Tumor-Initiating Cancer Stem Cells: Breaking the Diagnostic Barrier.
Topics: Biomarkers, Tumor; Cell Cycle Checkpoints; Cell Line, Tumor; Decitabine; Epigenesis, Genetic; Humans; Hydroxamic Acids; Lasers; Lung Neoplasms; Nanostructures; Neoplastic Stem Cells; Pancreatic Neoplasms; Phosphorus; Silicon; Spectrum Analysis, Raman | 2022 |